CIK 0001360214 · Large accelerated filer
HARROW, INC.
Sign in to watch- Ticker
- HROW
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 450567010
- Phone
- 615.733.4731
- Business address
- 1A BURTON HILLS BLVD, SUITE 200, NASHVILLE, TN
- Former names
- HARROW HEALTH, INC., Imprimis Pharmaceuticals, Inc., TRANSDEL PHARMACEUTICALS INC, Bywater Resources, Inc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 43 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-08-17 | Opaleye Management Inc. 10% owner | Purchase | +1,000 | $8.57 | $9K | 146,000 |
| 2021-07-23 | BAUM MARK L Chief Executive Officer | Grant or award · Restricted Stock Unit | +762,301 | 762,301 | ||
| 2021-07-23 | BOLL ANDREW R. Chief Financial Officer | Grant or award · Restricted Stock Unit | +346,500 | 346,500 | ||
| 2021-07-23 | SAHAREK JOHN P. President, ImprimisRx | Grant or award · Restricted Stock Unit | +277,200 | 277,200 | ||
| 2021-07-21 | Opaleye Management Inc. 10% owner | Purchase | +4,500 | $7.60 | $34K | 3,015,000 |
| 2021-07-21 | Opaleye Management Inc. 10% owner | Purchase | +4,706 | $7.60 | $36K | 145,000 |
| 2021-07-20 | Opaleye Management Inc. 10% owner | Purchase | +4,800 | $7.20 | $35K | 3,010,500 |
| 2021-07-20 | Opaleye Management Inc. 10% owner | Purchase | +125 | $7.20 | $900 | 140,294 |
| 2021-07-19 | Opaleye Management Inc. 10% owner | Purchase | +5,700 | $6.97 | $40K | 3,005,700 |
| 2021-07-19 | Opaleye Management Inc. 10% owner | Purchase | +169 | $6.97 | $1K | 140,169 |
| 2021-06-25 | LINDSTROM RICHARD L MD Director | Grant or award · RSU | +9,644 | 9,644 | ||
| 2021-06-25 | Kammer Robert J Director | Grant or award · RSU | +9,644 | 9,644 | ||
| 2021-06-25 | Van Horn R. Lawrence Director | Grant or award · RSU | +9,644 | 9,644 | ||
| 2021-06-25 | Sparks Teresa Director | Grant or award · RSU | +9,644 | 9,644 | ||
| 2021-06-18 | Opaleye Management Inc. 10% owner | Purchase | +59,800 | $8.35 | $499K | 3,000,000 |
| 2021-06-18 | Opaleye Management Inc. 10% owner | Purchase | +3,522 | $8.35 | $29K | 140,000 |
| 2021-06-17 | Opaleye Management Inc. 10% owner | Purchase | +10,800 | $8.32 | $90K | 2,940,200 |
| 2021-06-17 | Opaleye Management Inc. 10% owner | Purchase | +462 | $8.32 | $4K | 136,478 |
| 2021-05-20 | LINDSTROM RICHARD L MD Director | Sale | −10,000 | $10.75 | $108K | 90,000 |
| 2021-04-25 | BOLL ANDREW R. Chief Financial Officer | Option exercise | +127,500 | 273,000 |
Page 9 of 17 · 336 trades